©2013 DES Daughter DES Action Australia-NSW Media Alert Are you one of the 740,000 Australians at risk? New global health survey gives a voice to those suffering effects of ‘wonder drug’ that devastated generati…
Although less is known about the consequences of diethylstilbestrol exposure in men than in women, important DES health concerns have been identified.
Studies have not only linked prenatal diethylstilbestrol (DES) exposure to increased cancer and infertility rates in DES daughters, but the children of DES daughters may also be subject to birth defects because of DES prescribed to their…
Pregnant and told to take pharmaceuticals? Perhaps you can start by avoiding sources that are obviously drug-tainted. Remind yourself that thalidomide and DES were huge disasters, partly due to the biased information given to women.
Diethylstilbestrol or DES is the first synthetic man made female sex hormone (oestrogen) prescribed for public use mainly between 1938 and 1971 (but not limited to those years). Used primarily to prevent miscarriage and complications in pregnancy, diethylstilbestrol was a common medication administered by doctors in North America, Europe, and Australia for more than 40 years.
Higher incidence of clear cell adenocarcinoma of the cervix and vagina among women born between 1947 and 1971 in the United States
It is time to remember the DES legacy, including the lesson that prescription drug marketing cannot continue to upstage science. And prevent the same mistakes from being made again and again.
Diethylstilbestrol or DES was sold under many names including Distilbène®, Stilboestrol-Borne®, Benzestrol®, Chlorotrianisene®, Estrobene® and Estrosyn® to name just a few. Many companies manufactured and marketed this drug under more than 200 different brand names.
A large study of the daughters of women who had been given DES, the first synthetic form of estrogen, during pregnancy has found that exposure to the drug while in the womb (in utero) is associated with many reproductive …